ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
iShares 10 plus Year Investment Grade Corporate Bond ETF

iShares 10 plus Year Investment Grade Corporate Bond ETF (IGLB)

51.16
-0.19
(-0.37%)
Closed October 25 4:00PM
51.16
0.00
( 0.00% )
Pre Market: 6:00AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
51.16
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
44.88 52 Week Range 54.4199
Market Cap
Previous Close
51.16
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
840,413
Shares Outstanding
41,500,000
Dividend Yield
-
PE Ratio
21.21
Earnings Per Share (EPS)
2.41
Revenue
93.9M
Net Profit
100.09M

About iShares 10 plus Year Investment Grade Corporate Bond ETF

The investment seeks to track the investment results of the ICE BofA 10+ Year US Corporate Index. The fund generally will invest at least 90% of its assets in the component securities of the underlying index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash ... The investment seeks to track the investment results of the ICE BofA 10+ Year US Corporate Index. The fund generally will invest at least 90% of its assets in the component securities of the underlying index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The underlying index measures the performance of investment-grade corporate bonds of both U.S. and non-U.S. issuers that are U.S. dollar-denominated and publicly issued in the U.S. domestic market and have a remaining maturity of greater than or equal to ten years. Show more

Sector
Mgmt Invt Offices, Open-end
Industry
Mgmt Invt Offices, Open-end
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
iShares 10 plus Year Investment Grade Corporate Bond ETF is listed in the Mgmt Invt Offices, Open-end sector of the American Stock Exchange with ticker IGLB. The last closing price for iShares 10 plus Year Inv... was $51.16. Over the last year, iShares 10 plus Year Inv... shares have traded in a share price range of $ 44.88 to $ 54.4199.

iShares 10 plus Year Inv... currently has 41,500,000 shares outstanding. The market capitalization of iShares 10 plus Year Inv... is $2.12 billion. iShares 10 plus Year Inv... has a price to earnings ratio (PE ratio) of 21.21.

IGLB Latest News

Spine Pain Management, Inc. Delivers Positive Net Income in Its Third Quarter.

HOUSTON, Nov. 23 /PRNewswire-FirstCall/ -- Versa Card, Inc. (OTC Bulletin Board: IGLB), doing business as Spine Pain Management, Inc. (the "Company"), reported that its revenues for the quarter...

Spine Pain Management, Inc. Delivers Positive Net Income in Its Third Quarter.

HOUSTON, Nov. 23 /PRNewswire-FirstCall/ -- Versa Card, Inc. (OTC Bulletin Board: IGLB), doing business as Spine Pain Management, Inc. (the "Company"), reported that its revenues for the quarter...

Versa Card, Inc. Provides Update for Its Spine Treatment Centers

HOUSTON, Sept. 24 /PRNewswire-FirstCall/ -- Versa Card, Inc. (OTC Bulletin Board: IGLB), doing business as "Spine Pain Management, Inc." (the "Company"), is pleased to announce that the first...

Versa Card, Inc. Opens First Treatment Center for Spine Pain Management, Inc.

HOUSTON, Aug. 26 /PRNewswire-FirstCall/ -- Versa Card, Inc. (OTC Bulletin Board: IGLB), doing business as "Spine Pain Management, Inc." (the "Company"), has entered into a Medical Services...

VERSA CARD, INC., Formerly Intrepid Global Imaging 3D, Inc., Completes Acquisition of Asian Based Smartcard Company

The Philippines Based Company Has Extensive Strategic Ties To Commercial, Banking And Governmental Interests Throughout Asia MANILA, Philippines & PHILADELPHIA, April 29 /PRNewswire-FirstCall/...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.57-1.1018751208251.7351.7650.9912103098551.2585077SP
4-2.55-4.7477192329253.7153.8650.991279806452.3829218SP
12-0.94-1.8042226487552.154.419950.9284041352.82600064SP
262.014.0895218718249.1554.419948.7170164251.79657372SP
526.0313.361400398845.1354.419944.8882116651.10129192SP
156-19.37-27.463490713270.5371.8744.45565633754.11728864SP
260-14.64-22.249240121665.874.4244.45558070858.8784336SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
HCTIHealthcare Triangle Inc
$ 1.345
(132.30%)
19.51M
PXDTPixie Dust Technologies Inc
$ 1.34
(100.00%)
1.37M
BSLKBolt Projects Holdings Inc
$ 0.5655
(39.66%)
41
BCLIBrainstorm Cell Therapeutics Inc
$ 2.60
(32.68%)
77
TWGTop Wealth Group Holding Ltd
$ 0.67
(24.17%)
11.8M
GDTCCytoMed Therapeutics Ltd
$ 1.21
(-56.94%)
32
SMXSMX Security Matters Public Company
$ 0.60
(-56.83%)
200.17k
UPXIUpexi Inc
$ 6.34
(-21.73%)
40.57k
FGIFGI Industries Ltd
$ 0.81
(-17.07%)
744.19k
ARBBARB IOT Group Ltd
$ 0.5706
(-16.59%)
390.8k
HCTIHealthcare Triangle Inc
$ 1.345
(132.30%)
19.51M
JTAIJet AI Inc
$ 0.0722
(6.33%)
16.55M
TWGTop Wealth Group Holding Ltd
$ 0.67
(24.17%)
11.8M
VIRXViracta Therapeutics Inc
$ 0.3075
(16.48%)
11.27M
TCBPTC BioPharm Holdings PLC
$ 1.84
(15.00%)
2.5M

Discussion

View Full Feed
flptrnkng flptrnkng 10 minutes ago
From about 10 days ago, on the NV SOS site.

You should probably spend the 3 bucks, or whatever it is, to get a fresh copy of the Amendment for yourself.

Or not. IGPK needs good holders of the bag, before they reverse and transform into JFHE.
IGPK
PioneerUniverse8 PioneerUniverse8 10 minutes ago
The stock is up 21% in pre hours. trading at $5.67

IMO, This is incredible arbitrage opportunity. The deal will go through, I am 100% sure and I am buying
RVNC
777guy 777guy 12 minutes ago
Looks like they added "including offer price" this time:

Company’s ongoing discussions with the Buyer Parties could result in further delays to the commencement or consummation of the Offer, or in the Company or the Buyer Parties seeking remedies in accordance with, and modifications
RVNC
LVerstee LVerstee 15 minutes ago
Listening for 6 years to somebody who has cost you money and still believing him makes you what?
ITUP
LVerstee LVerstee 20 minutes ago
And kidding himself in the process

https://investorshub.advfn.com/uimage/uploads/2024/10/28/fztxscreating-your-own-meaning-is-just-like-tying-a-carrot-on-v0-px4l9zsc4i3c1.jpg
ITUP
Golden Cross Golden Cross 22 minutes ago
$ILLR It’s Official: Triller Has Become the Go-To Replacement for Users Fleeing TikTok in Light of the Pending Ban
https://graziamagazine.com/us/articles/triller-has-become-the-replacement-for-users-fleeing-tiktok-in-light-of-the-pending-ban/
ILLR
LVerstee LVerstee 22 minutes ago
Same 💩 different 🚽

https://investorshub.advfn.com/uimage/uploads/2024/10/28/sxkhodangling-carrot.png
HERB
Golden Cross Golden Cross 23 minutes ago
$ILLR It’s Official: Triller Has Become the Go-To Replacement for Users Fleeing TikTok in Light of the Pending Ban
https://graziamagazine.com/us/articles/triller-has-become-the-replacement-for-users-fleeing-tiktok-in-light-of-the-pending-ban/
ILLR
NASDAQ2020 NASDAQ2020 23 minutes ago
Palms are itching.

?
ELTP
kid70 kid70 24 minutes ago
The 90.day mark will.be here soon.  If we are only still.hearing from one side of the story, you can belive Mike is 100 percent telling the truth.   
UBQU
linkvest linkvest 27 minutes ago
Must be something from years ago dude.. I'm not even sure that is from IGPK LOL... no name, date, stock symbol, nothing... nice try but I think you are full of chit...
IGPK
weedtrader420 weedtrader420 28 minutes ago
DOGEX 💡Upchurch HI-DEAS 2
DOGEUSD
FeMike FeMike 32 minutes ago
I ASSUME that the current compassionate use treatment price is basically cost. That means it does not include any development cost amortization or profit. If anyone has more insight in to that I'd appreciate additional information on that subject.

Compassionate use is well above cost
NWBO
Edward Edward 35 minutes ago
So in the end he "vigorously" failed to offer ANY defense w/in the allotted time.

Doesn't matter. At some point he will have tp defend VXIT, the SEC is not going to forget about this,although he has no real defense.
Many shares will have to be issued to pay for the Lawyers.
VXIT
LTListener LTListener 35 minutes ago
Some of the avenues of research for ampa or gabakines are interesting, but it is clear in filings and commentary that the company leadership is working on creating value along 3 platforms.

Ampakines - CX1739 DOD/SCI phase 2 and they mentioned ADHD with either CX1739 or CX717
Ga
RSPI
jimr1717 jimr1717 35 minutes ago
One may wonder when the automobile was invented were people posting about the accidents, head on collisions and fires and comparing them to their horse and buggies?
“I ain’t getting into one of those, Jethro almost lost his life.”
They need to outlaw those things, they are scaring t
TSLA
gregcod gregcod 42 minutes ago
t would be nice to get some good official news on whats going on with IBAT at this time especially when the smackover regions holding all that lithium brine from Texas, Louisianna, and Arkansas..Galvanic Energys CEO Brent Wilson sold that 120,000 acres of prime lithium smackover brine to Exxon Mobi
IBATF
777guy 777guy 43 minutes ago
The Distribution Agreement is amended. Parties specifically agree there are no further items in dispute. Teoxane gets Daxxify marketing rights in Australia and NZ. Tender start extension to Nov 1.

https://www.sec.gov/Archives/edgar/data/1479290/000114036124044317/ef20037731_8k.htm
RVNC
LTListener LTListener 45 minutes ago
It doesnt make sense for them to be trading on this expert market in the first place, so trying to guess when they emerge will be tough. They have a big DOD funded clinical "supposedly" to begin by end of this year or basically next 8 weeks. Is this going to happen or pushed to Q1 2025?
RSPI
ksquared ksquared 46 minutes ago
The beautiful thing...
https://nypost.com/wp-content/uploads/sites/2/2024/10/Front-cover-10-28-2024.jpg?resize=394,441&quality=90&strip=all&w=750
LTListener LTListener 51 minutes ago
I do think it is both interesting and telling that they are spending effort the 6+ months on summarizing, publicizing information and details that make the case for their premier ampa and gaba compounds as both platforms are poised to be in clinicals soon.
RSPI
TrendTrade2016 TrendTrade2016 52 minutes ago
VIRX ON THE MOVE
VIRX

Your Recent History

Delayed Upgrade Clock